Cytopharma Oncology
Tunisian oncology drug manufacturer producing injectable cytotoxic medicines for hospital pharmacies.
Cytopharma Oncology specializes in manufacturing injectable oncology drugs including cytotoxic preparations for hospital pharmacies and oncology centers in Tunisia, Algeria, and Morocco. The Zaghouan facility is one of few specialized cytotoxic drug manufacturers in North Africa.
- Type
- Manufacturer
- Location
- Zaghouan, Tunisia
- Founded
- 2003
- Website
- https://www.cytopharma.com.tn
- Categories
- Medical & Healthcare Supplies
- Markets
- Tunisia, Algeria, Morocco
Verified facts
- certificate-page-on-site (amber), checked 2026-08-11 Company's own certification page
- web-presence-since (green), checked 2026-08-05 Internet Archive (Wayback)
- sanctions-clear (green), checked 2026-08-05 OpenSanctions
- debarment-clear (green), checked 2026-08-05 OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-05 Mail server of the company domain
Claimed certifications
- Good Manufacturing Practice
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)